| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | Karlin Daniel Chief Medical Officer | Sale | -8,018 | -1.90%413,317 | $18.47 | $148,092 | View SEC filing | |
| 2026-03-26 | Sullivan Mark Chief Legal Officer | Sale | -10,702 | -3.80%271,079 | $18.47 | $197,666 | View SEC filing | |
| 2026-03-26 | Barrow Robert Chief Executive Officer | Sale | -24,431 | -3.14%752,454 | $18.47 | $451,241 | View SEC filing | |
| 2025-12-29 | Karlin Daniel Chief Medical Officer | Sale | -5,600 | -1.30%425,025 | $13.15 | $73,623 | View SEC filing | |
| 2025-12-29 | Barrow Robert Chief Executive Officer | Sale | -25,791 | -3.21%778,477 | $13.15 | $339,072 | View SEC filing | |
| 2025-12-29 | Sullivan Mark Chief Legal Officer | Sale | -11,276 | -3.84%282,576 | $13.15 | $148,244 | View SEC filing | |
| 2025-09-26 | Sullivan Mark Chief Legal Officer | Sale | -11,278 | -3.70%293,852 | $9.77 | $110,186 | View SEC filing | |
| 2025-09-26 | Barrow Robert Chief Executive Officer | Sale | -25,797 | -3.11%804,268 | $9.77 | $252,037 | View SEC filing | |
| 2025-09-26 | Karlin Daniel Chief Medical Officer | Sale | -7,704 | -1.76%430,625 | $9.77 | $75,268 | View SEC filing | |
| 2025-06-26 | Sullivan Mark Chief Legal Officer | Sale | -11,491 | -3.63%305,130 | $6.80 | $78,139 | View SEC filing | |
| 2025-06-26 | Karlin Daniel Chief Medical Officer | Sale | -7,848 | -1.76%438,329 | $6.80 | $53,366 | View SEC filing | |
| 2025-06-26 | Barrow Robert Chief Executive Officer | Sale | -26,491 | -3.09%830,065 | $6.80 | $180,139 | View SEC filing | |
| 2025-03-26 | Barrow Robert Chief Executive Officer | Sale | -21,208 | -2.42%856,556 | $6.74 | $142,942 | View SEC filing | |
| 2025-03-26 | Karlin Daniel Chief Medical Officer | Sale | -6,836 | -1.51%446,177 | $6.74 | $46,075 | View SEC filing | |
| 2025-03-26 | Sullivan Mark Chief Legal Officer | Sale | -6,576 | -2.03%316,621 | $6.74 | $44,322 | View SEC filing | |
| 2025-03-26 | Liao Carrie Chief Accounting Officer | Sale | -2,347 | -1.59%144,923 | $6.74 | $15,819 | View SEC filing | |
| 2024-12-27 | Barrow Robert Chief Executive Officer | Sale | -19,106 | -3.50%526,666 | $7.43 | $141,958 | View SEC filing | |
| 2024-12-27 | Liao Carrie Chief Accounting Officer | Sale | -2,273 | -2.28%97,270 | $7.43 | $16,888 | View SEC filing | |
| 2024-12-27 | Karlin Dan Chief Medical Officer | Sale | -6,643 | -1.93%338,013 | $7.43 | $49,357 | View SEC filing | |
| 2024-12-27 | Sullivan Mark Chief Legal Officer | Sale | -4,519 | -2.54%173,197 | $7.43 | $33,576 | View SEC filing | |
| 2024-12-05 | GRYSKA DAVID W Director | Purchase | +2,500 | +14.41%19,851 | $7.17 | $17,925 | View SEC filing | |
| 2024-09-25 | Liao Carrie Chief Accounting Officer | Sale | -2,352 | -2.31%99,543 | $5.98 | $14,065 | View SEC filing | |
| 2024-09-25 | Barrow Robert Chief Executive Officer | Sale | -19,771 | -3.50%545,772 | $5.98 | $118,231 | View SEC filing | |
| 2024-09-25 | Karlin Dan Chief Medical Officer | Sale | -6,871 | -1.95%344,656 | $5.98 | $41,089 | View SEC filing | |
| 2024-09-25 | Sullivan Mark Chief Legal Officer | Sale | -4,430 | -2.43%177,716 | $5.98 | $26,491 | View SEC filing |
1-25 of 65
